Perspective Therapeutics (CATX) announced the appointment of Joel Sendek as the Company’s CFO. Sendek previously served as CFO at four biotech companies: Dewpoint Therapeutics, Sema4, Spero Therapeutics, and Forward Pharma. Sendek is succeeding Juan Graham, who will be leaving the Company.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CATX:
- Perspective Therapeutics management to meet with Oppenheimer
- Perspective Therapeutics Appoints Maya Martinez-Davis to Board
- Perspective Therapeutics appoints Maya Martinez-Davis to board of directors
- Perspective Therapeutics Updates on Radiopharmaceutical Advancements
- Promising Clinical Pipeline and Strategic Investments Justify Buy Rating for Perspective Therapeutics